Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 10.620% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CCOC(=O)c1c(C)c(C)n(Cc2ccc(OC)c(OC)c2)c1C
(b) NC(=NC(=O)c1ccc(Cl)cc1)N1N=CCC1c1ccccc1
Answer: b. NC(=NC(=O)c1ccc(Cl)cc1)N1N=CCC1c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
NC(=NC(=O)c1ccc(Cl)cc1)N1N=CCC1c1ccccc1
NC(=NC(=O)c1ccc(Cl)cc1)N1N=CCC1c1ccccc1
N-[amino-(3-phenyl-3,4-dihydropyrazol-2-yl)methylidene]-4-chlorobenzamide